STOCK TITAN

Qiming Entities Disclose 5.97% Stake in Zai Lab (66.3M Shares)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Qiming-affiliated investors report beneficial ownership of 66,329,320 ordinary shares of Zai Lab, representing 5.97% of the outstanding class. The disclosed position is held through QM11 Limited and related Cayman entities and is composed, per the filing, of 1,268,000 ADSs and 53,649,320 ordinary shares that together total the reported 66,329,320 shares.

Breakdown in the filing shows Qiming Corporate GP IV, Ltd. and QM11 Limited with sole voting and dispositive power over the 66,329,320 shares, while related Qiming entities report shared voting/dispositive power of 64,299,112 shares (5.79%) and 2,030,208 shares (0.18%). The percentage is calculated using 1,110,783,740 ordinary shares outstanding, as disclosed by the issuer.

Positive

  • Disclosure of a material stake: The filing reports a clear beneficial ownership of 66,329,320 shares, representing 5.97% of the class, which improves market transparency.
  • Structured ownership detail: The filing provides a precise breakdown of voting and dispositive power across named Qiming entities and QM11 Limited, aiding investor assessment.

Negative

  • None.

Insights

TL;DR: A passive 5.97% stake by Qiming signals meaningful institutional interest but does not imply control.

The filing documents a total beneficial holding of 66,329,320 Zai Lab ordinary shares, equivalent to 5.97% of the issuer's 1,110,783,740 outstanding shares used for the calculation. As a Schedule 13G amendment, this reflects disclosure of ownership rather than an active proxy or control intent. For investors, the development is material as a transparency event demonstrating concentrated institutional exposure, though it does not alter governance or control dynamics by itself.

TL;DR: Ownership is routed through offshore entities and a holding company, with limited sole control beyond disclosure.

The ownership structure shows the position held primarily via QM11 Limited 66,329,320 shares, while related partnership vehicles report shared power over 64,299,112 and 2,030,208 shares respectively. This layered structure is typical for institutional investments and important for assessing who can exercise voting influence, but the filing contains no indication of coordinated activism or control changes.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Note to Row (5) (7) and (9): As of the date of this 13G/A filing, Qiming Corporate GP IV, Ltd. is the general partner of Qiming Managing Directors Fund IV, L.P. and Qiming GP IV, L.P. Qiming Managing Directors Fund IV, L.P. holds approximately 3.06% of the equity interest of QM11 Limited. Qiming GP IV, L.P. is the general partner of Qiming Venture Partners IV, L.P., which holds approximately 96.94% of the equity interest of QM11 Limited. QM11 Limited is the owner of 66,329,320 Ordinary Shares, which is consisted of 1,268,000 ADSs and 53,649,320 ordinary shares. Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Row (6) (8) and (9): As of the date of this 13G/A filing, Qiming Managing Directors Fund IV, L.P. holds approximately 3.06% of the equity interest of QM11 Limited, which is the owner of 66,329,320 Ordinary Shares (in the form of 1,268,000 ADSs and 53,649,320 ordinary shares). Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Row (6) (8) and (9): As of the date of this 13G/A filing, Qiming GP IV, L.P. is the general partner of Qiming Venture Partners IV, L.P., which owns approximately 96.94% of the equity interest of QM11 Limited, which is the owner of 66,329,320 Ordinary Shares (in the form of 1,268,000 ADSs and 53,649,320 ordinary shares). Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Row (6) (8) and (9): As of the date of this 13G/A filing, Qiming Venture Partners IV, L.P. holds approximately 96.94% of the equity interest of QM11 Limited, which is the owner of 66,329,320 Ordinary Shares (in the form of 1,268,000 ADSs and 53,649,320 ordinary shares). Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Row (11): The percentage is calculated based upon an aggregate of 1,110,783,740 Ordinary Shares outstanding as of June 30, 2025, which is based on the information disclosed by the Issuer on July 7, 2025.


SCHEDULE 13G



Qiming Corporate GP IV, Ltd.
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
Qiming Managing Directors Fund IV, L.P
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
Qiming GP IV, L.P
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
Qiming Venture Partners IV, L.P.
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
QM11 Limited
Signature:/s/ Holan Lam
Name/Title:Holan Lam/Authorized Signatory
Date:08/12/2025
Exhibit Information

Exhibit A Joint Filing Agreement dated February 13, 2019 https://www.sec.gov/Archives/edgar/data/1704292/000095010319001958/dp102255_sc13ga-zai.htm

FAQ

Who filed the Schedule 13G/A for Zai Lab (ZLAB)?

The filing was made by Qiming Corporate GP IV, Ltd., Qiming Managing Directors Fund IV, L.P., Qiming GP IV, L.P., Qiming Venture Partners IV, L.P. and QM11 Limited.

How many Zai Lab (ZLAB) shares does the Qiming group report owning?

The group reports beneficial ownership of 66,329,320 ordinary shares, representing 5.97% of the class.

How is the 66,329,320-share position composed?

The filing states QM11 Limited's holding consists of 1,268,000 ADSs and 53,649,320 ordinary shares, summing to the reported total.

What voting and dispositive power do the filers have over ZLAB shares?

Qiming Corporate GP IV, Ltd. and QM11 Limited report sole voting and dispositive power over the 66,329,320 shares; related Qiming entities report shared voting/dispositive power of 64,299,112 and 2,030,208 shares.

What basis was used to calculate the percentage ownership?

The percentage is calculated using 1,110,783,740 ordinary shares outstanding, per the issuer's disclosure referenced in the filing.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

2.04B
106.96M
1.74%
42.53%
4.26%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI